New Amsterdam Pharma has raised $196M in total funding. Latest round: Series A. Backed by Forbion, Morningside Ventures, Ascendant BioCapital.
New Amsterdam Pharma has raised $196M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in August 2020. The round record for New Amsterdam Pharma runs through 2020; nothing later has been disclosed. Investors on record include Forbion, Morningside Ventures, Ascendant BioCapital, Kaiser Foundation Hospitals, BVF Partners L.P., Population Health Partners and 8 others. 14 distinct backers are named across the disclosed rounds.
Round data for New Amsterdam Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026